Phenotypic methods are a consistent means of detecting antimicrobial resistance (AMR) as they are well established and cost-effective. Although not as rapid as molecular methods, they are the most standardised method available, and the Mast Group offers a comprehensive range of antibiotic sensitivity testing (AST), identification (ID) and combination discs for the reliable detection of extended-spectrum β-lactamase (ESBL), AmpC and carbapenemase enzymes in Gram-negative Enterobacteriaceae.
In the research environment, clinical trials of antimicrobials require the design of diagnostic devices to determine microorganism susceptibility before the compound enters clinical trials, and Mast can also supply mastpharma, a range of services tailored to the evaluation of new antimicrobial compounds.